Add-on Treatment with Rituximab Did Not Improve Lupus Nephrititis According to New Study

Results of a newly-published study showed that adding rituximab to mycophenolate mofetil and corticosteroids does not improve outcomes in patients with lupus nephritis. Rituximab is approved for treating Non-Hodgkin's lymphoma, a type of cancer of the immune system.

Full Story